Skip to main
IRTC

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 46%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Holdings is well-positioned in the digital healthcare market with its innovative technology and strategic acquisitions. The company has shown strong performance with raised revenue guidance and plans for further expansion through the acquisition of VitalConnect. With a positive outlook for continued growth, it is a promising investment in the increasingly important healthcare technology sector.

Bears say

iRhythm Holdings is performing well, with solid revenue and EBITDA beats in the second quarter and consistent revenue growth above 20% every quarter. Innovative channel partners are a key contributor to this growth, and the company expects continued success in this area. While the FDA warning letter may pose a challenge, management is confident in their remediation efforts and has a strong plan in place. Additionally, the company has identified opportunities for growth through their home sleep test pilot program, which leverages their existing customer base and addresses a fragmented market.

iRhythm Technologies (IRTC) has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 46% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 13 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $173.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $173.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.